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Objective: Catheter ablation of persistent atrial fibrillation (AF) is still challenging, no
optimal extra-pulmonary vein lesion set is known. We previously reported the clinical
feasibility of computational modeling-guided AF catheter ablation.
Methods: We randomly assigned 118 patients with persistent AF (77.8% men, age
60.8 ± 9.9 years) to the computational modeling-guided ablation group (53 patients)
and the empirical ablation group (55 patients) based on the operators’ experience. For
virtual ablation, four virtual linear and one electrogram-guided lesion sets were tested
on patient heart computed tomogram-based models, and the lesion set with the fastest
termination time was reported to the operator in the modeling-guided ablation group.
The primary outcome was freedom from atrial tachyarrhythmias lasting longer than 30 s
after a single procedure.
Results: During 31.5 ± 9.4 months, virtual ablation procedures were available in
95.2% of the patients (108/118). Clinical recurrence rate was significantly lower after
a modeling-guided ablation than after an empirical ablation (20.8 vs. 40.0%, log-rank
p = 0.042). Modeling-guided ablation was independently associated with a better long-
term rhythm outcome of persistent AF ablation (HR = 0.29 [0.12–0.69], p = 0.005). The
rhythm outcome of the modeling-guided ablation showed better trends in males, non-
obese patients with a less remodeled atrium (left atrial dimension < 50 mm), ejection
fraction ≥ 50%, and those without hypertension or diabetes (p < 0.01). There were
no significant differences between the groups for the total procedure time (p = 0.403),
ablation time (p = 0.510), and major complication rate (p = 0.900).
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Conclusion: Among patients with persistent AF, the computational modeling-guided
ablation was superior to the empirical catheter ablation regarding the rhythm outcome.
Clinical Trial Registration: This study was registered with the ClinicalTrials.gov,
number NCT02171364.
Keywords: atrial fibrillation, catheter ablation, virtual ablation, computational modeling, recurrence
INTRODUCTION
Catheter ablation is an effective and established rhythm
control strategy in patients with anti-arrhythmic drug-resistant
atrial fibrillation (AF) (Calkins et al., 2012). Nevertheless,
catheter ablation of persistent AF (PeAF) or longstanding
PeAF is a challenging procedure, and the post-procedural
recurrence rate is still substantially high (Verma et al.,
2015). This is because extra-pulmonary vein (PV) triggers
are more common in patients with PeAF (Pak et al.,
2006), but they cannot be treated with circumferential PV
isolation (CPVI) alone. Thus, empirical extra-PV ablation
for substrate modification strategies has been applied for
patients with PeAF (Willems et al., 2006) and has been
shown to be beneficial (Knecht et al., 2008). Linear ablation
may improve the rhythm outcome by a reduction in the
critical mass and exit block of extra-PV triggers, despite the
difficulty to obtain long-lasting bidirectional block of linear
lesions (Kim et al., 2016). Whereas, a randomized clinical
trial failed to prove the beneficial effect of empirical extra-
PV ablation compared to the CPVI in patients with PeAF
(Verma et al., 2015). Therefore, personalized, focused, and
effective ablation strategies are required, rather than a routine
empirical extra-PV left atrial (LA) ablation with extensive
cardiac tissue damage.
Recently, computational modeling has been making
remarkable progress, and its clinical usefulness is gradually
increasing. Computational AF modeling reflecting a
sophisticated histology such as fibrosis and a personalized
fiber orientation using magnetic resonance imaging (MRI)-
late gadolinium enhancement has been developed and is
now applicable to clinical data (Jacquemet, 2015; Trayanova
et al., 2018). Because the wave-dynamics mechanism of
AF is highly affected by the atrial anatomy and surface
curvature (Song et al., 2018), we hypothesized that a
customized extra-PV ablation according to the anatomy of
the atrium would reduce the recurrence rate after PeAF
or longstanding PeAF ablation. The purpose of this study
was to evaluate the effect of a computational modeling-
guided AF ablation to improve the rhythm outcome of PeAF
ablation as compared to an empirical treatment conducted
by experts. Five different linear and electrogram-guided
virtual ablation methods were tested with an AF modeling
reflecting the patients left atrial (LA) anatomy obtained
from heart computed tomography (CT) images before the
procedure. The pre-determined lesion set with the best
virtual AF termination was provided to operators of the
computational modeling-guided ablation group; however, the
operators of the empirical ablation group were blinded to the
simulation outcome.
MATERIALS AND METHODS
Study Design and Population
This study was a randomized, open-label, multicenter trial
involving patients with non-valvular AF undergoing catheter
ablation (ClinicalTrials.gov; NCT 02171364). The study protocol
adhered to the Declaration of Helsinki and was approved by the
institutional review board of each participating center. Written
informed consent was obtained from all patients. The study
design and results of the CUVIA-AF 1 trial have been reported
(Shim et al., 2017). The study cohort included 118 patients
(77·8% men, age 60·8 ± 9·9 years) who underwent catheter
ablation of symptomatic and drug-refractory non-valvular PeAF
at six tertiary hospitals in Korea. Key exclusion criteria were as
follows: (1) patients younger than 20 or older than 80 years; (2)
valvular AF; (3) significant structural heart disease other than
left ventricular hypertrophy; (4) an LA diameter of 60 mm or
more, and (5) a history of previous AF ablation or cardiac surgery.
The anatomy of the LA and PVs was visually defined by three-
dimensional (3D) CT scans (64 Channel, Light Speed Volume
CT, Philips, Brilliance 63, Amsterdam, Netherlands). All anti-
arrhythmic drugs (AADs) were discontinued for a period of at
least five half-lives.
The enrolled patients were randomly assigned to either the
computational modeling-guided ablation group or the empirical
ablation group (Figure 1). For all patients in both groups, digital
images and communication in medicine (DICOM) files of the
cardiac CT images were sent to the core lab, and AF modeling
and virtual ablation tests were conducted before the clinical AF
ablation. The ablation lesion sets were categorized by applying
the following five strategies: (1) CPVI alone, (2) CPVI and an
additional posterior box lesion (POBI) (Hwang et al., 2014; Kim
et al., 2016), (3) additional POBI and an anterior linear (AL)
ablation (Shim et al., 2017), (4) additional roof line (RL) and a
left lateral isthmus (LLI) line (Haissaguerre et al., 2005), and (5)
an additional complex fractionated atrial electrogram (CFAE)-
guided ablation (Nademanee et al., 2004; Hwang et al., 2014).
Among the five different ablation lesions, the best virtual ablation
lesion set was determined by the earliest termination of the
virtual AF with the simulation modeling study. For patients in the
computational modeling-guided ablation group, the operator was
informed about the best virtual ablation strategy and applied the
clinical AF ablation procedure. In the empirical ablation group,
the ablation lesion set was selected by the operator based on his
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FIGURE 1 | Study flow diagram. The enrolled patients were randomly assigned to either the computational modeling-guided ablation group or the empirical ablation
group. PeAF, persistent atrial fibrillation; RFCA, radiofrequency catheter ablation.
or her experience. The primary end point was AF recurrence after
a single procedure, and the secondary end point was a recurrence
pattern, the response to AADs, and the cardioversion rate. All
ablation procedures were performed by physicians with at least
10 years of experience.
Computational Modeling of AF
After receiving consent from the patients, DICOM files of the
heart CT images were sent to the core laboratory the night before
or early in the morning of the AF ablation procedure. The patient
randomization, computational AF modeling, and virtual AF
ablation were performed at the core laboratory during working
hours (9 a.m.–6 p.m.). Among 118 patients, four were excluded
for incorrect selection and six were excluded due to a failed virtual
AF ablation due to DICOM file errors or communication errors.
Finally, 108 patients were enrolled and randomly assigned into
two groups: 53 in the computational modeling-guided ablation
group and 55 in the empirical ablation group (Figure 1). The
patient characteristics are shown in Table 1.
The LA geometries of the patients included were
reconstructed from the 3D CT DICOM files defining the
surface of the LA. A triangular mesh was generated with a
prism-type element applying a constant thickness of 1.89 mm
on the surface of the 3D LA geometry (Beinart et al., 2011;
Hwang et al., 2014). The final number of grid elements was set
between 400,000 and 500,000. The LA appendage structure and
myocardial sleeves of the LA (Pashakhanloo et al., 2016) were
also included in the mesh. For the computational modeling of
the cardiac wave propagation in the atrial wall, the following
reaction-diffusion equation was used (Zozor et al., 2003):
∂Vm
∂t
= 1
βCm
{∇ · D∇Vm − β (Iion + Is)} , (1)
where Vm (volt) is the membrane potential; β (meter−1) is the
membrane surface-to-volume ratio; Cm (farad/meter2) is the
membrane capacitance per unit area; D (siemens/meter) is the
conductivity tensor; and Iion and Is (ampere/meter2) are the ion
current and stimulation current, respectively. To simulate the
reaction-diffusion system, we constructed the models using a
generalized finite difference scheme which can effectively lower
dimensionality and can reduce computing time with parallel
computational modeling with graphics processing unit system
(Zozor et al., 2003).
For the calculation of ionic currents, a mathematical model
of the human atrial action potential was used (Courtemanche
et al., 1998). Electrical stimulation was applied at the location of
Bachmann’s bundle, and reentry was initiated by rapid pacing: a
total of 24 paces (eight paces per each pacing cycle length) with
pacing cycle lengths of 200, 190, and 180 ms. The ionic currents in
each cell were determined using the human atrial myocyte model
applied by modified model from that of Courtemanche et al.
(1998) To replicate the electrical remodeling associated with AF
in the cell model, the conductances of Ito, ICaL, IKur , and IK1 were
changed by−80,−40,−50, and+50%, respectively, as described
previously by us (Shim et al., 2017) and others (Dossel et al., 2012;
Wilhelms et al., 2012). We chose a conduction velocity (CV) of
0.4 m/s based on human patient data (Yonsei AF ablation cohort
data; n = 1,980; mean CV = 0.43 ± 0.24 m/s) (Park et al., 2014)
and previous modeling studies (Hwang et al., 2014).
Virtual AF Ablation
Virtual ablation was performed for all 108 patients in both the
computational modeling-guided and empirical ablation groups.
We developed a graphical user interface software, which had
already been introduced (Shim et al., 2017), with which the user
can perform virtual ablation by mouse-clicking on the atrial
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TABLE 1 | Baseline clinical characteristics.
Overall (N = 108) Simulation-guided ablation (N = 53) Empirical ablation (N = 55) p-Value
Age (years) 60.8 ± 9.6 59.7 ± 10.1 61.9 ± 9.6 0.240
Male, n (%) (76.9%) (75.5%) (78.2%) 0.821
Longstanding persistent AF (%) (77.8%) (83.0%) (72.7%) 0.249
AF duration 44.1 ± 55.6 39.4 ± 58.1 48.3 ± 53.5 0.441
Follow-up duration, months 31.5 ± 9.4 31.7 ± 9.3 31.3 ± 9.5 0.830
BMI (kg/m2) 25.3 ± 3.1 25.7 ± 3.5 24.8 ± 2.6 0.129
CHA2DS2–VASc score 2.0 ± 1.9 1.9 ± 1.7 2.1 ± 1.9 0.475
Congestive heart failure (%) (12.0%) (9.4%) (14.5%) 0.557
Hypertension (%) (54.6%) (52.8%) (56.4%) 0.847
Age ≥ 75 years (%) (9.3%) (3.8%) (14.5%) 0.094
Age 65–74 years (%) (25.0%) (28.3%) (21.8%) 0.508
Diabetes (%) (18.5%) (17.0%) (20.0%) 0.806
Previous stroke (%) (28.7%) (28.3%) (29.1%) >0.999
Previous TIA (%) (1.9%) (3.8%) (0.0%) 0.238
Vascular disease (%) (13.0%) (9.4%) (16.4%) 0.392
Echocardiographic parameters (Pre-RFCA)
LA diameter (mm) 45.1 ± 4.4 46.1 ± 7.6 44.0 ± 4.4 0.086
LA volume index (mL/m2) 44.4 ± 14.8 45.0 ± 15.7 43.8 ± 14.0 0.718
LV EF (%) 59.3 ± 9.7 57.8 ± 7.8 60.7 ± 9.7 0.092
E/Em 10.2 ± 4.7 9.6 ± 3.0 10.7 ± 4.7 0.139
AAD, antiarrhythmic drug; ACEi, angiotensin-converting-enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; BSA, body surface area; E, early
diastolic transmitral flow velocity; Em, early diastolic mitral annular velocity; ECV, electrical cardioversion; LA, left atrium; L-PeAF, long-standing persistent atrial fibrillation;
LV EF, left ventricular ejection fraction; RFCA, radiofrequency catheter ablation; TIA, transient ischemic attack.
FIGURE 2 | Five different protocols of virtual ablation. AL, left atrial anterior linear line; CFAE, complex fragmented atrial electrogram; CPVI, circumferential pulmonary
vein isolation; LLI, left atrial left lateral isthmus line; POBI, posterior box isolation; Roof, left atrial roof line.
geometry (CUVIA, Model: SH01, ver. 1.0; Laonmed, Inc., Seoul,
South Korea). The ablation patterns of each of the five protocols
are shown in Figure 2. At the ablated lesion points, the membrane
potential was permanently set to the resting value (−80.6 mV)
to generate conduction block. For the CFAE-guided ablation, the
areas of CFAEs with a cycle length (CFAE CL) of less than 120 ms
were ablated starting from the lowest CFAE CL area as long as the
total ablated area was less than 5% of the total atrial area. Mitral
annular area was set as non-conductive area. Virtual ablation
was applied 4 s after the end of pacing. Computational modeling
was applied for 25 s, and the duration lasted until the fibrillation
termination was recorded for each ablation protocol. Virtual AF
termination was determined as the time to the total extinction
of the wavelet (90% repolarization) in the entire LA. A graphical
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user interface was developed using the C++ order to perform
each virtual ablation on the virtual atrium of each patient.
Clinical AF Ablation
Electrophysiological mapping and radiofrequency catheter
ablation (RFCA) have been described previously (Shim
et al., 2017). Briefly, we used an open irrigated-tip catheter
(Thermocool [Johnson & Johnson, Inc., Diamond Bar, CA,
United States] or Coolflex [St. Jude Medical]; 30–35W, 47◦C)
to deliver radiofrequency energy for the ablation under 3D
electroanatomical mapping (NavX, St. Jude Medical; CARTO3,
Johnson & Johnson) merged with the 3D spiral CT. All patients
underwent a CPVI in both groups. After CPVI, bidirectional
block was confirmed in all patients. Extra-PV ablation was
performed based on the virtual ablation outcome in the
computational modeling-guided ablation group and was based
on the operator’s discretion in the empirical ablation group.
The procedure was completed when there was no immediate
recurrence of AF after cardioversion with an isoproterenol
infusion (up to 5 µg/min). All RFCA procedures were performed
by an operator with over 10 years of experience.
Post-ablation Management and
Follow-Up
After the procedure, we maintained AADs for 3 months in
58.3% of the included patients, as the majority had longstanding
persistent AF (78% of included patients). Then, we tried to
stop AAD if there was no recurred AF in the post-procedure
3rd month Holter. Patients visited the outpatient clinic at
one, three, six, and 12 months after the RFCA or whenever
symptoms occurred. All patients underwent electrocardiography
at each visit, and 24-h Holter recording was performed
at 3, 6, and 12 months, and every 6 months thereafter,
according to the 2012 Heart Rhythm Society/European Heart
Rhythm Association/European Cardiac Arrhythmia Society
Expert Consensus Statement (Calkins et al., 2012). When patients
reported palpitations, Holter or event monitor recordings were
obtained to check for arrhythmia recurrence. We defined
recurrence as any episode of AF or atrial tachycardia (AT) lasting
for at least 30 s. Any electrocardiography documentation of an
AF recurrence after a 3 months blanking period was diagnosed as
a clinical recurrence.
Statistical Analysis
Continuous variables were compared with a Student’s t-test,
and categorical variables were compared with either the chi-
square test or Fisher’s exact test, as appropriate. The primary
endpoint was the freedom from any atrial arrhythmias during
the follow-up after a 3- month blanking period. The time to
recurrence and arrhythmia-free survival were assessed with a
Kaplan–Meier analysis, and differences were calculated with
the log-rank test. To assess the factors associated with a post-
RFCA clinical recurrence of AF, we used a Cox proportional-
hazard model regression analysis. p-Values of < 0.05 were
considered statistically significant. All statistical analyses were
performed using SPSS version 25.0 software (SPSS, Inc., Chicago,
IL, United States).
RESULTS
Baseline Characteristics
We enrolled 118 patients with persistent AF for catheter ablation
in the CUVIA AF trial. Among them, 10 were excluded due
to a failed virtual ablation before starting the clinical procedure
(n = 6), wrong patient selection (n = 2), or upon patient request
(n = 2); finally, 108 patients (95.2%) were randomized (Figure 1).
All included patients initiated the clinical AF ablation procedure
after finishing the virtual AF ablation. Eventually, 53 patients
were properly and randomly allocated to the computational
modeling-guided ablation group, and 55 were allocated to the
empirical ablation group (Figure 1). The patient characteristics
are summarized in Table 1. The mean age was 61 years, 77% were
male, and the overall follow-up duration was 31.5 months. The
proportion of longstanding PeAF (sustaining more than 1 year)
was 78% (83.0% in the modeling-guided ablation group vs. 72.7%
in the empirical ablation group, p = 0.249). The mean CHA2DS2-
VASc score was 2.0± 1.9 and mean LA dimension 45.1± 4.4 mm.
There were no statistically significant differences in the patient
characteristics between the groups.
Virtual Ablation Outcome
Per the study protocol, a virtual ablation was performed in
all included patients before starting the clinical AF ablation;
however, the results were blinded for the empirical ablation
group. The pre-ablation computing time for simulating the five
virtual ablation strategies described previously was 166± 11 min.
One hour was required for the heart CT segmentation with
a semi-automatic method and settings of five different virtual
ablation lesion sets by the manual method. Computing the virtual
AF induction and five protocol-based virtual AF ablation lesions
required one more hour, and an additional 30 min was required
for calculating the CFAE area. The outcomes of the virtual AF
ablation are summarized in Table 2. We determined the virtual
AF termination by waiting 25 s after the virtual AF ablation.
Among the five different virtual ablation lesion sets, the POBI
and AL ablation after the CPVI [CPVI + POBI + AL] had
the highest AF termination rate (81.5%, p < 0.001 vs. CPVI
alone) and shortest time to AF termination (16.8± 5.7 s). Virtual
ablation of the RL and LLI after the CPVI [CPVI + RL + LLI]
had the second highest termination rate (73.1%, p < 0.001 vs.
CPVI alone) within 25 s. The virtual AF termination rates were
followed by a POBI after the CPVI [CPVI + POBI] (28.7%,
p < 0.001 vs. CPVI), CPVI alone (11.1%), and CFAE ablation
after the CPVI [CPVI + CFAE] (8.3%, Table 2). There was no
significant difference in the virtual ablation outcome between the
[CPVI+ CFAE] and [CPVI alone] groups.
Comparison of Procedural
Characteristics
The procedural results and clinical outcomes are summarized
in Table 3. The total procedure times, ablation times, and
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TABLE 2 | Virtual ablation outcomes.
Overall (N = 108) Simulation-guided ablation (N = 53) Empirical ablation (N = 55) p-Value
Conduction velocity (m/s) 0.41 ± 0.11 0.40 ± 0.07 0.41 ± 0.14 0.615
APD90 (ms) 213 ± 2 213 ± 2 213 ± 3 0.618
AF termination rate (%)
CPVI 11.1 (12/108) 9.4 (5/53) 12.7 (7/55) 0.761
CPVI + POBI 28.7 (31/108) ∗ 34.0 (18/53) ∗ 23.6 (13/55) 0.289
CPVI + POBI + AL 81.5 (88/108) ∗ 83.0 (44/53) ∗ 80.0 (44/55) ∗ 0.806
CPVI + RL + LLI 73.1 (79/108) ∗ 75.5 (40/53) ∗ 70.9 (39/55) ∗ 0.667
CPVI + CFAE 8.3 (9/108) 7.5 (4/53) 9.1 (5/55) 1
Time to AF termination (ms)
CPVI 23914 ± 3466 24017 ± 3354 23815 ± 3599 0.763
CPVI + POBI 21893 ± 5471 21463 ± 5719 22307 ± 5240 0.426
CPVI + POBI + AL 16792 ± 5672 16478 ± 5750 17094 ± 5633 0.575
CPVI + RL + LLI 17701 ± 5770 17199 ± 5949 18185 ± 5604 0.378
CPVI + CFAE 24170 ± 3041 24319 ± 2686 24018 ± 3385 0.619
∗p < 0.001 compared with the CPVI of each group.APD90, action potential duration of 90% repolarization; CPVI, circumferential pulmonary vein isolation; POBI, posterior
box isolation; AL, anterior line; RL, roof line; LLI, left lateral isthmus line; CFAE, complex fractionated atrial electrogram guided ablation.
TABLE 3 | Procedure-related characteristics and the clinical rhythm outcomes.
Overall (N = 108) Simulation-guided ablation (N = 53) Empirical ablation (N = 55) p-Value
Procedure time (min) 264 ± 89 256 ± 69 272 ± 105 0.403
Ablation time (sec) 5122 ± 2575 4955 ± 2804 5273 ± 2368 0.510
Fluoroscopic time (min) 57 ± 30 59 ± 31 55 ± 30 0.523
Complication rate,% (n) 4.2% (4/108) 4.4% (2/53) 4.0% (2/55) 0.900
AAD utilization rate at discharge,% (n) 58.3% (63/108) 64.2% (34/53) 52.7% (29/55) 0.233
AAD utilization rate after 3 months,% (n) 53.7% (58/108) 64.2% (34/53) 43.6% (24/55) 0.108
AAD utilization at clinical recurrence,% (n) 38.9% (42/108) 45.3% (24/53) 32.7% (18/55) 0.184
Class Ic AAD,% (n) 22.2% (24/108) 28.3% (15/53) 16.4% (9/55) 0.138
Class III AAD,% (n) 18.5% (20/108) 18.9% (10/53) 18.2% (10/55) 0.928
Procedural lesion set,% (n)
CPVI 16.7% (18/108) 1.9% (1/53) 30.9% (17/55) <0.001
CPVI + POBI 6.5% (7/108) 11.3% (6/53) 1.8% (1/55) 0.058
CPVI + POBI + AL 38.0% (41/108) 39.6% (21/53) 36.4% (20/55) 0.843
CPVI + RL + LLI 33.3% (36/108) 43.4% (23/53) 23.6% (13/55) 0.041
CPVI + CFAE 5.6% (6/108) 3.8% (2/53) 7.3% (4/55) 0.679
Bidirectional block rates of linear lesions
POBI,% (n) 56.3% (27/48) 55.6% (15/27) 57.1% (12/21) 0.914
RL,% (n) 78.6% (66/84) 72.0% (36/50) 83.3% (30/34) 0.157
AL,% (n) 85.4% (35/41) 76.2% (16/21) 95.0% (19/20) 0.093
LLI,% (n) 44.4% (16/36) 39.1% (9/23) 53.8% (7/13) 0.408
Early recurrence,% (n) 31.5% (34/108) 28.3% (15/53) 34.5% (19/55) 0.490
Clinical recurrence,% (n) 30.6% (33/108) 20.8% (11/53) 40.0% (22/55) 0.030
CPVI 22.2% (4/18) 0% (0/1) 23.5% (4/17) 0.468
CPVI + POBI 0% (0/7) 0% (0/6) 0% (0/1) -
CPVI + POBI + AL 26.8% (11/41) 23.8% (5/21) 30.0% (6/20) 0.664
CPVI + RL + LLI 41.7% (15/36) 21.7% (5/23) 76.9% (10/13) <0.001
CPVI + CFAE 16.7% (1/6) 0% (0/2) 25.0% (1/4) 0.541
Clinical recurrence as AT,% (n) 33.3% (11/33) 9.1% (1/11) 45.5% (10/22) 0.038
Clinical recurrence requiring cardioversion,% (n) 16.7% (18/108) 15.1% (8/53) 18.2% (10/55) 0.670
Final sinus rhythm,% (n) 93.5% (101/108) 98.1% (52/53) 89.1% (49/55) 0.058
Final sinus rhythm without AADs,% (n) 58.3% (63/108) 52.8% (28/53) 63.6% (35/55) 0.259
AAD, antiarrhythmic drug; AL, anterior line; CFAE, complex fractionated atrial electrogram guided ablation; CPVI, circumferential pulmonary vein isolation; LLI, left lateral
isthmus line; POBI, posterior box isolation; RL, roof line. Bold values indicate statistical significance at p < 0.05.
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complication rates did not significantly differ between the groups.
The AAD maintenance rates did not significantly differ between
the two groups (45.3% in the computational modeling-guided
ablation group vs. 32.7% in the empirical ablation group,
p = 0.184). Compared to the modeling-guided ablation group,
the ablation lesion sets with the CPVI alone were more common
(30.9 vs. 1.9%, p < 0.001), while additional RL and LLI ablation
after the CPVI [CPVI + RL + LLI] was less common (23.6
vs. 43.4%, p = 0.041) in the empirical ablation group. The
bidirectional block rates for each linear ablation lesion did not
significantly differ between the two groups (Table 3).
Primary Outcome
During the 37.1 ± 11.6 months of follow-up, the early
recurrence rate within 3 months after the procedure did
not significantly differ between the computational modeling-
guided ablation group (28.3%) and empirical ablation group
(34.5%, p = 0.490). However, the clinical recurrence rate after
3 months of catheter ablation was significantly lower in the
modeling-guided ablation group (20.8%) than in the empirical
ablation group (40.0%, p = 0.030, Table 3). A Kaplan–Meier
analysis showed a significantly lower recurrence of AF/AT
in the modeling-guided ablation group than in the empirical
ablation group (log-rank p = 0.042, Figure 3A). This difference
was significant in the patients who were taking AADs after
the catheter ablation (log-rank p = 0.004, Figure 3B), but
not in those without AADs (log-rank p = 0.204, Figure 3C).
The presence of bidirectional block of the linear ablation
lesions did not affect the clinical recurrence rate (23.1%
in the modeling-guided group vs. 39.4% in the empirical
ablation group, p = 0.138). Using a multivariable-adjusted Cox
proportional hazards model regression analysis, compared with
the empirical AF ablation, we found that the computational
modeling-guided AF ablation reduced the clinical recurrence
rate by 71% (HR 0.29 [0.12–0.69], p = 0.005, Table 4). In
the sub-group analyses, the computational modeling-guided
AF ablation showed better trends of rhythm outcome in the
male individuals, non-obese individuals, patients with a left
ventricular ejection fraction of ≥ 50%, E/Em of < 15, LA
dimension of < 50 mm, and those without hypertension or
diabetes (Figure 4).
Secondary Outcome
Among a total of 33 patients with clinical recurrence, 22 had AF
and 11 had AT at the time of the recurrence. Among the patients
with clinical recurrence, the proportion of AT (9.1% [1/11] vs.
45.5% [10/22], p = 0.038) were lower in computational modeling-
guided ablation group, but those requiring cardioversion (72.7%
[8/11] vs. 45.5% [10/22], p = 0.147) did not significantly differ
between the two groups (Table 3). Among all included patients,
15.1% (8/53) of those in the modeling-guided ablation group
and 18.2% (10/55) of those in the empirical ablation group
underwent cardioversion to control AAD resistant recurred
atrial arrhythmias (Table 3). Repeat ablation procedures were
performed in 14 patients (11.3% in the modeling-guided ablation
group vs. 14.5% in the empirical ablation group, p = 0.622),
and reconnected PV potentials were found in 21.4% (3/14) in
the modeling-guided ablation group and 42.9% (6/14) in the
empirical ablation group (p = 0.240).
DISCUSSION
Main Findings
In this study, we generated a highly efficient patient-specific
computational AF modeling, which could be applied to the
clinical AF ablation procedure. In this first multi-center
prospective randomized clinical trial of 118 patients with PeAF
(77.8% with longstanding PeAF), the modeling-guided ablation
group applied the lesion set of the fastest virtual AF termination
after comparing five different virtual lesion sets. During the mean
31.5 months follow-up, the computational modeling-guided
ablation results were superior to the empirical catheter ablation
results regarding the rhythm outcome. The rhythm outcome
of the computational modeling-guided ablation showed better
trends in patients with a less structurally remodeled atrium.
PeAF Ablation: Unanswered Continuous
Challenge
Atrial fibrillation catheter ablation has been proven to reduce
the AF burden, heart failure mortality (Marrouche et al.,
2018), and stroke risk, and it also improves the cognitive and
renal function (Takahashi et al., 2011; Calkins et al., 2012).
Although the CPVI is a cornerstone lesion of AF ablation
in both paroxysmal and PeAF (Verma et al., 2015), the 1-
year rhythm outcome is not satisfactory in patients with PeAF
with multiple extra-PV triggers (Pak et al., 2006). Thus, an
empirical extra-PV ablation for a substrate modification has
been applied in patients with PeAF for many years and is
known to be beneficial (Wynn et al., 2014). However, the
recent prospective randomized clinical trial, STAR-AF2, failed to
prove its usefulness (Verma et al., 2015). Therefore, personalized
extra-PV AF rotors or drivers have been traced by clinical
investigators (Narayan et al., 2014). We also demonstrated the
effectiveness of a virtual ablation targeting AF spiral wave
reentries represented by a high dominant frequency area in
the computational modeling study (Hwang et al., 2016), but
the majority were non-stationary rotors that were affected by
the local conduction velocity (Narayan et al., 2014). Currently,
catheter ablation targeting these non-stationary hypothetical
triggers is controversial in patients with PeAF (Calkins et al.,
2012). Rather, we need a more reproducible and clinically
feasible sophisticated mapping technique reflecting the patient-
specific anatomy and electrophysiology that affects the AF
wave-dynamics.
Current Technology of Computational AF
Modeling
Cardiac computational modeling has a growing role and allows
for the non-invasive identification of spiral wave reentries in
AF (Lim et al., 2017). Although the contemporary clinical
3D electroanatomical mapping system has enabled contact
electrogram-based mapping of the atrium in detail, it is not
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FIGURE 3 | Kaplan–Meier curves according to patients with AAD usage. (A) Overall patients. (B) Patients with maintaining AAD use after catheter ablation.
(C) Patients without maintaining AAD use after catheter ablation. AAD, antiarrhythmic drug.
TABLE 4 | Factors associated with a post-RFCA clinical recurrence of AF (Cox proportional-hazard model regression analysis).
Variables Univariable adjusted Multivariable adjusted
HR (95% CI) p-Value HR (95% CI) p-Value
Male 0.86 (0.35–2.07) 0.728 0.98 (0.37–2.63) 0.966
Age (years) 0.99 (0.96–1.03) 0.859 0.97 (0.93–1.01) 0.128
AF duration 1.00 (0.99–1.01) 0.397 1.00 (0.99–1.01) 0.608
CHA2-DS2-VASc 0.97 (0.79–1.19) 0.750
Heart failure 0.41 (0.10–1.71) 0.220
Hypertension 1.19 (0.60–2.38) 0.617
Diabetes 0.70 (0.27–1.82) 0.467
Previous stroke/TIA 1.25 (0.54–2.88) 0.603
Vascular disease 0.84 (0.30–2.40) 0.747
Baseline LA AP diameter (mm) 1.01 (0.96–1.06) 0.714 1.02 (0.97–1.07) 0.523
Baseline LV EF (%) 1.01 (0.97–1.06) 0.663
Baseline E/Em 0.88 (0.73–1.02) 0.108
Post-RFCA AAD use 2.09 (0.92–4.30) 0.082 2.46 (0.57–4.63) 0.102
Simulation-guided ablation 0.48 (0.23–0.99) 0.048 0.29 (0.12–0.69) 0.005
AAD, antiarrhythmic drug; CI, confidence interval; E, early diastolic transmitral flow velocity; Em, early diastolic mitral annular velocity; HR, hazard ratio; LA AP, left
atrial anterior–posterior; LV EF, left ventricular ejection fraction; PeAF, persistent atrial fibrillation; RFCA, radiofrequency catheter ablation; TIA, transient ischemic attack;
simulation-guided ablation, virtual in silico model guided catheter ablation. Bold values indicate statistical significance at p < 0.05.
possible to identify non-stationary AF drivers by point-to-
point catheter mapping. The entire chamber mapping, such
as focal impulse and rotor mapping (FIRM) (Narayan et al.,
2014) or panoramic mapping (Haissaguerre et al., 2014), has
a limitation in its spatial resolution. In recent years, high-
performance computational simulation technology has enabled
patient-specific AF modeling that reflects MRI-defined fibrosis,
the fiber orientation, and the tissue thickness, and has been
clinically applied (Supplementary Table 1) (Jacquemet, 2015).
With this sophisticated computational modeling, high-density
entire chamber mapping of AF, reflecting a personalized anatomy
and histology, is possible. However, the long computing time
is the major limitation for the application of this sophisticated
and realistic AF modeling to clinical practice. Therefore,
we generated a high-speed high-density (half million nodes)
chamber-centric AF computational modeling integrated with
the patient-specific atrial anatomy. A graphics processing unit
system was used to sufficiently improve the computational
speed to be applicable for clinical AF ablation (Hwang et al.,
2014). We also validated its reproducibility in a retrospective
clinical study (Hwang et al., 2014) and feasibility (Shim
et al., 2017) and efficacy in this prospective clinical study.
Although it is technically possible, we did not incorporated
patient-specific atrial fibrosis or fiber orientation in this study
because of computational speed issue. In order to apply
more sophisticated patient-specific information that is acquired
during the on-site procedure, the technological innovation that
can increase the computation speed is expected. However,
AF is a multifactorial systemic degenerative disease and its
rhythm outcome can be affected by metabolic factors, such
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FIGURE 4 | Age- and sex-adjusted HR for post-RFCA clinical recurrence of AF according to subgroups (Cox proportional-hazard model regression analysis). AF,
atrial fibrillation; AP diameter, antero-posterior diameter; BMI, body mass index; DM, diabetes mellitus; EF, ejection fraction; E/Em, the ratio of early transmitral flow
velocity (E) to early mitral annular velocity (Em); HR, hazard ratio; HTN, hypertension.
as obesity (Mahajan et al., 2018), pericardial fat volume
(Kim et al., 2014) and obstructive sleep apnea (Dimitri
et al., 2012). Since CUVIA computational modeling reflects
the characteristics of patients’ atrium proper, its predictive
value might be higher in non-obese patients with less
remodeled atria.
Limitations and Future Clinical
Applications
Although we applied the patient-specific atrial anatomy for
our AF modeling study, it was a monolayer homogeneous
model. This modeling study is only related to anatomical
factor and their clear relation with AF activation patterns
remains unclear. While the atrial thickness variations, epicardial
conduction (Hansen et al., 2016), and myofiber orientation
could affect the cardiac wave propagation (Hansen et al., 2015),
the wave propagation pattern of the monolayer model is very
similar to that of the bilayer model (Labarthe et al., 2014).
Reflection of the atrial wall thickness may improve the cardiac
wave dynamics analyses as well as the RF energy titration
during clinical AF ablation procedures in the future. A more
realistic AF computational modeling application is under way,
applying the contact electrogram voltage and local activation
pattern acquired during the AF ablation procedure and the
atrial wall thickness obtained from atrial imaging. Therefore,
it is challenging to further reduce the computing simulation
time to generate an upgraded system applicable in in situ
procedures. Although we used irrigated-tip catheters for clinical
AF ablation, we did not use contact-force technology nor ablation
lesion index in this study. Additionally, although patients were
followed as the guideline (Calkins et al., 2012), 24-h Holter
recording at 3, 6, 12 months is relatively overestimates the
success, therefore, careful interpretation is needed (Verma et al.,
2013). The lack of a continuous rhythm recording, such as
implantable loop recorder, may alter the outcome by detection
of silent and/or short AF recurrences. Although randomization
was performed by a central randomization service independent
of investigators, the number of patients with AADs after the
procedure tend to be more in computational modeling-guided
ablation group than in empirical ablation group; however, the
difference was not statistically significant (p > 0.10). Therefore,
careful interpretation is needed in this respect. In order to
make this study outcome more appealing and realistic, a
larger study population will be needed. The individuals in this
study were limited to PeAF patients, and the outcome of this
study cannot be extrapolated to other types of AF or the
entire AF population.
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CONCLUSION
We tested the feasibility and efficacy of highly efficient
patient-specific computational AF modeling in a multi-
center prospective randomized clinical trial. During the
mean 31.5 months follow-up, the computational modeling-
guided ablation was superior to the empirical catheter
ablation regarding the rhythm outcome. The rhythm
outcome of the computational modeling-guided ablation
showed better trends in patients with a less structurally
remodeled atrium.
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